Introduction
The correlation between tumor proliferation and neovascularization has been studied in various carcinomas ever since it was reported by Folkman 1) in 1971. Neovascularization is also considered to be closely associated with the proliferation / metastasis of tumors in breast cancer, and some reports have suggested the possibility of using this as an independent prognostic factor2-12), As an assessment method that reflects the degree of neovascularization, the microvascular density of a tumor is often measured in tissue sections obtained from immunostained sam- 
Subjects and Methods

Subjects
One hundred and forty-four patients who had undergone surgical resection of primary breast cancer at our hospital during the two-year period from 1998 to 1999 were included in this study (Table 1 ). Treatments were not administered to any of the patients prior to the operation, and post-operational adjuvant therapy was performed according to the operational method and the stage of the disease. The mean observation period for these patients was 68 months. In April 2005, there were 115 surviving patients, 24 deaths , and 5 unknown cases. Among the deaths, 20 were due to breast cancer, and 4 were associated with other causes .
Methods
Thin sections (thickness : 3 ,um) were prepared for immunohistochemical studies from formalin-fixed paraffin-embedded blocks containing tumor margins. Immunostaining was performed using the ChemMate EnVision Detection kit (DakoCytomation, Denmark). The anti-human CD34 monoclonal antibody (1: 50; QBEnd10, DakoCytomation , Denmark) and anti-human nestin monoclonal antibody (1: 50; 10C2, Santa Cruz Biotechnology , Santa Cruz, CA, U S.A.) were used as primary antibodies.
Three fields were randomly selected under high magnification from the immunostained tumor margin samples using a light microscope, and microvascular densities were calculated by adding the numbers of CD34-and nestin-positive blood vessels in each field ( Fig. 1 ). These were missing elastic lamina and forming tubular structures. The correlations between microvascular densities and clinical pathological factors, and between microvascular densities and patient prognoses were calculated. Statistical assessments were made using the Mann-Whitney test, in which P < 0.05 was defined as being statistically significant . Relapse-free survival and overall survival included the period following the operations until death or until observations had been completed. The following clinicopathological factors were assessed to determine whether these correlated with the microvascular density of the tumor : age, tumor diameter, lymph node metastasis, distant metastasis, lymphatic vessel invasion, nuclear grade (NG), estrogen receptor (ER), and progesterone receptor (PgR) ( Table 2 ). To assess the relationship with tumor diameters, separate assessments were made for tumors with different TNM classifications, and included T1 tumors (< 2 cm), T2 tumors (2-5 cm), and T3 tumors (> 5 cm). Microvascular densities were significantly higher in tumors with large diameters in CD34-stained samples only. To assess the nuclear grade (NG) of the tumor, separate assessments were made for tumors with different nuclear grades as described in the Breast Cancer Handling Conventions in Japan (Vol. 15), and included NG1 + 2 and NG3 tumors. Microvascular densities were significantly higher in NG3 tumors in both CD34-and nestin-stained samples.
Results
Relationship between microvascular density and clinicopathological factors
Separate assessments were also made for the estrogen (ER) and progesterone (PgR) hormone receptors. Negative results were defined as those in which the ratio of positively stained cells was less than 10%, and positive results as those with a ratio of 10% or higher.
Significant differences in microvascular densities were observed in nestin-positive samples expressing ER, and in CD34-and nestin-positive samples expressing PgR.
Relationship between microvascular density and overall survival
The mean values of the microvascular densities calculated with CD34 and nestin were 7.51 and 7.91, respectively. When the relationship between these values and overall survival (OS) was studied separately for the low-value group (less than 7) and the high-value group (7 or more), the OS was significantly shorter in the high-value group with both CD34 and nestin (Fig. 2 ). In the present study, the clinicopathological factors that were significantly correlated with microvascular densities were the presence of lymph node metastases and distant metastases, lymphatic duct invasion, tumor diameter, nuclear grade, presence of hormone receptors, and overall survival. These results emphasize that microvascular density measurements are an effective indicator of metastasis and patient prognosis in breast cancer patients, just as they are in other carcinomas. In contrast, the correlation between microvascular densities and hormone receptors is considered to be an aspect specific to breast cancer. Furthermore, neovascularization is induced by various factors associated with cancer proliferation22), and the fact that microvascular densities tended to be lower in elderly patients in this study corresponds to reports stating that neovascularization is suppressed by decreases in estrogen concentrations 23, 24). Although further studies must be conducted to gain a better understanding of breast cancer and to develop treatment applications for breast cancer in relation to microvascular densities, it will also be necessary to consider the assessment of breast cancer-specific factors that are associated with the induction of neovascularization. Conclusion A significant correlation was observed between microvascular densities, which were measured using CD34 and nestin immunostaining, and metastasis and disease prognosis in the breast cancer cases treated in our hospital.
Discussion
